Leading the charge at AstraZeneca's Oncology R&D Data Science, my role is to harness the power of AI and computer vision to discover imaging augmented multi-modal biomarkers and craft cutting-edge diagnostic tools that improve cancer outcomes. My team's efforts in developing ML/DL algorithms and synthetic control arms are pivotal in advancing patient selection, and response prediction. Collaboration is a cornerstone of our work; by forging strong networks with academic and industry partners, we've established comprehensive imaging workflows that dovetail seamlessly with omics and clinical data. This synergy not only bolsters our oncology R&D endeavors but also embodies my commitment to delivering personalized healthcare solutions. My expertise in signal processing, computer vision and AI/ML approaches, combined with a resolute focus on patient needs underpins our mission to revolutionize cancer care and sustain innovation.